Women infected with HIV type 1 Brazilian variant, subtype B (B′-GWGR Motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR Motif)

Clinical Infectious Diseases

Volumn 43, Issue 11, 2006, Pages 1476-1481

  De Brito, Adriana ^a   Komninakis, Shirley C V ^d   Novoa, Patrícia ^a,c   De Oliveira, Rafael M ^a   Fonseca, Luiz Augusto M ^b   Duarte, Alberto J S ^a   Casseb, Jorge ^a,b,c  

^a Clinical Immunology and Rheumatology   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Emilio Ribas Infectious Diseases Institute   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE; TRYPTOPHAN; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; DISEASE COURSE; FATALITY; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEROTYPE; SEX DIFFERENCE; STRAIN DIFFERENCE; VIRUS DIAGNOSIS; VIRUS ENVELOPE; VIRUS LOAD; VIRUS STRAIN; VIRUS TYPING;

ADULT; BRAZIL; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 33751581204     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508875     Document Type: Article

References (35)

1. Zagury JF, Franchini G, Reitz, M, et al. Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. Proc Natl Acad Sci U S A 1988;85:5941-5.
2. Alison M, Montagnier L. Genetic variability in human immunodeficiency viruses. Ann N Y Acad Sci 1987; 511:376-84.
3. Wyatt R, Desjardin E, Olshevsky U, et al. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein. J Virol 1997; 71:9722-31.
4. Buonaguro L, Gaudio ED, Monaco M, et al., the Italian-Ugandan Cooperation AIDS Program. Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus types 1 isolates from Gulu, northern Uganda. J Virol 1995; 69:7971-81.
5. Ivanoff LA, Dibay JW, Morris JF, et al. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology 1992; 187:423-32.
6. Scott CF Jr, Silver S, Profy AT, et al. Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain. Proc Natl Acad Sci U S A 1990; 87:8597-601.
7. De Rossi A, Pasti M, Mammano F, et al. Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism. Virology 1991; 184:187-96.
8. Gallo RC. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol Rev 2002; 185:236-65.
9. Huang CC, Tang M, Zhang MY, et al. Structure of a V3-containing HIV-1 gp120 core. Science 2005; 310:1025-8.
10. Hartley O, Klasse PJ, Sattentau QJ, Moore JP. V3: HIV's switch-hitter. AIDS Res Hum Retroviruses 2005; 21:171-89.
11. Javaherian K, Langlois AJ, McDanal C, et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A 1989; 86:6768-72.
12. Moore JP, Parren PW, Burton DR. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 2001; 75:5721-9.
13. Senkaali D, Muwonge R, Morgan D, et al. The relationship between HIV type 1 disease progression and V3 serotype in rural Ugandan cohort. AIDS Res Hum Retroviruses 2004; 9:932-7.
14. Sabino EC, Diaz RS, Brígido LF, et al. Distribution of HIV-1 subtypes seen in an AIDS clinic in São Paulo City, Brazil. AIDS 1996; 10:1579-84.
15. Couto-Fernandez JC, Janssens W, Heyndrickx L, et al. Genetic and antigenic variability of HIV-1 type 1 in Brazil. AIDS Res Hum Retroviruses 1994; 10:1157-63.
16. Costa SM, Schechter M, Shindo N, et al. Sequence and phylogenetic analysis of glycoprotein 120 of an HIV type 1 variant (GWGR) prevalent in Brazil. AIDS Res Hum Retroviruses 1995; 11:1143-5.
17. Casseb J, Hong MA, Gonzalez C, Brígido LF, Duarte AJS. Two variants of HIV-1 B serotype are transmitted heterosexually in São Paulo, Brazil. Braz J Med Biol Res 1998; 31:943-6.
18. Morgado MG, Sabino EC, Shpaer KG, et al. V3 polymorphism in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses 1994; 10:569-76.
19. Louwagie J, Delwart EL, Mullins JI, McCutchan FE, Eddy G, Burke DS. Genetic analysis of HIV-1 isolates from Brazil revels presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses 1994; 10:561-7.
20. Covas DT, Bíscaro TA, Kashima S, Duarte G, Machado AA. High frequency of the GWG (Pro Trp) envelope variant of HIV-1 in Southeast Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:74-9.
21. Morgado MG, Guimarães ML, Gripp CBG, et al. Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of HIV-1 subtype D infection in Rio de Janeiro, Brazil. J Acquir Immune Defic Synd Hum Retrovirol 1998; 18:488-94.
22. Potts KE, Kalish ML, Lott T, et al. Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. AIDS 1993; 7:1191-7.
23. Kanki PG, Hamel DJ, Sankalé JL, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179:68-73.
24. Casseb J, Montanheiro P, Komninakis S, Brito A, Duarte AJS. Human immunodeficiency virus type 1 (HIV-1) Brazilian subtype B variant (B′-GWGR Motif) showed an increasing avidity of the anti-V3 antibodies over time compared to the subtype B US/European strain in São Paulo, Brazil. Mem Inst Oswaldo Cruz 2004; 99:69-71.
25. Barin F, Laperche S, Courouce AM. Genetic diversity of viruses: consequences for screening and prevention. Transfus Clin Biol 2000; 7:472-8.
26. Casseb J, Komninakis S, Abdalla L, et al. HIV disease progression: Is the Brazilian variant subtype B′(GWGR motif) less pathogenic than US/European subtype B (GPGR)? Int J Infect Dis 2002; 6:64-9.
27. Santnro-Lopes G, Harrison LH, Tavares MD, Xexeo A, dos Santos AC, Schechter M. HIV disease progression and V3 serotypes in Brazil: is B different from B′. AIDS Res Hum Retroviruses 2000; 16:953-8.
28. Hendry RM, Hanson CV, Bongertz V, et al. Immunoreactivity of Brazilian HIV isolates with different V3 motifs. Mem Inst Oswaldo Cruz 1996; 91:347-8.
29. Brostrom C, Sonnenberg A, Sallberg M. Human immunodeficiency virus (HIV) type 1 - infected patients with no disease progression display high-avidity antibody productionologous V3 sequences. J Infect Dis 1995; 171:509-11.
30. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:1-19.
31. + T-cell recovery and clinical outcome in HIV-1-infected patients exposed to multiple antiretroviral regimens: partial control of viremia is associated with favorable outcome. AIDS Patient Care STDS 2004; 18:189-98.
32. Casseb J, Fonseca LA, Veiga AP, et al. AIDS incidence and mortality in a hospital-based cohort of HIV-1-seropositive patients receiving highly active antiretroviral therapy in Sao Paulo, Brazil. AIDS Patient Care STDS 2003; 17:447-52.
33. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005; 11:411-23.
34. Vasan A, Renjifo B, Hertzmark E, et al. Different rates of disease propression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-52.
35. Garcia de la Hera M, Ferreros I, del Amo J, et al., GEMES. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. J Epidemiol Community Health 2004; 58:944-50.